## Abstract Our current knowledge of NK‐cell recognition and effector function suggests that it will be possible to design various new NK‐cell‐based immunotherapies against human cancer. The application of NK cells is already showing promise using HLA‐mismatched haematopoietic stem cell transplanta
Can NK cells be a therapeutic target in human type 1 diabetes?
✍ Scribed by Francesco Dotta; Cecilia Fondelli; Alberto Falorni
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 73 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Type 1 diabetes is caused by the autoimmune destruction of insulin‐producing cells with consequent hyperglycemia and serious chronic complications. Both innate and adaptive immune responses participate in disease pathogenesis. Studies in animal models and in man have shown that NK cells are involved both in disease progression and in disease protection, thus suggesting that NK cells can represent a potential therapeutic target in type 1 diabetes, once the contribution of these cells to islet autoimmunity has been fully elucidated.
📜 SIMILAR VOLUMES
## Abstract ## Objective Angiotensin II (Ang II) is known to have proinflammatory actions, and Ang II type 1 (AT~1~) receptors are up‐regulated in the rheumatoid synovium, suggesting that this receptor could be a therapeutic target. The purpose of this study was to investigate the antiinflammatory
## Abstract Jujuy province, in Northwest Argentina, is known to be endemic for HTLV‐1 infection. Moreover, foci of HTLV‐1 associated pathologies have also been described in this region. To gain an insight into the current situation of HTLV‐1/2 in this endemic area, a seroprevalence and phylogenetic